TerminatedNot applicableNCT05506449
The RECOVER IV Trial
Studying Cardiogenic shock
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Abiomed Inc.
- Principal Investigator
- Navin Kapur, MDTufts Medical Center
- Intervention
- Impella CP®(device)
- Enrollment
- 4 enrolled
- Eligibility
- 18-90 years · All sexes
- Timeline
- 2023 – 2024
Study locations (7)
- New Mexico Heart Institute, Albuquerque, New Mexico, United States
- Rigshospitalet Copenhagen, Copenhagen, Denmark
- Herzzentrum Dresden, Dresden, Saxony, Germany
- University Hospital Düsseldorf, Düsseldorf, Germany
- Universitatsklinikum Schleswig Holstein, Kiel, Germany
- Krankenhaus der Barmherzigen Brüder Trier, Trier, Germany
- Inselspital Bern, Bern, Switzerland
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05506449 on ClinicalTrials.govOther trials for Cardiogenic shock
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE4NCT07527156Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureInstitute for Clinical and Experimental Medicine
- RECRUITINGNANCT07345559Personalisation of Mean Arterial Pressure in Adult Patients With Cardiogenic ShockCMC Ambroise Paré
- RECRUITINGNANCT07374289On Scene ECPR in OstravaUniversity Hospital Ostrava
- RECRUITINGNCT07402018Intra-aortic Balloon Counterpulsation (IABC) ComplianceThomas Jefferson University
- RECRUITINGNCT07309029Pre-Emptive LAVA-ECMO for Complex High-Risk TAVRAtlantic Health System
- RECRUITINGNANCT07293923Magenta Elevate™ Clinical Feasibility Study in Cardiogenic ShockMagenta Medical Ltd.
- RECRUITINGNCT07354568Prognosis of Patients With Mixed Cardiogenic-Vasoplegic ShockCentre Hospitalier Universitaire, Amiens
- RECRUITINGNCT06964685Assessment of Support With Impella® Best Practices in Acute Myocardial Infarction Complicated by Cardiogenic ShockAbiomed Inc.